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Abstract
The sensor retinoic acid-inducible gene-I (RIG-I) detects double-stranded RNA derived from RNA 
viruses. Although RIG-I is also known to play a role in the antiviral response to DNA viruses, 
physiological RNA species recognized by RIG-I during DNA virus infection are largely unknown. 
Using next-generation RNA sequencing (RNAseq), we found that host-derived RNAs, most 
prominently 5S ribosomal RNA pseudogene 141 (RNA5SP141), bind to RIG-I during herpes 
simplex virus 1 (HSV-1) infection. HSV-1 infection induced relocalization of RNA5SP141 from 
the nucleus to the cytoplasm, and virus-induced shutoff of host protein synthesis downregulated 
RNA5SP141-interacting proteins, thereby allowing RNA5SP141 to bind RIG-I and induce type I 
interferon. Silencing of RNA5SP141 strongly dampened the antiviral response to HSV-1 and the 
related Epstein-Barr virus (EBV) as well as influenza A virus (IAV). Our findings reveal that 
antiviral immunity can be triggered by host RNAs that are unshielded following viral depletion of 
their respective binding proteins.
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INTRODUCTION
The mammalian innate immune system surveils infected cells for the presence of microbes 
using a defined repertoire of pattern-recognition receptors (PRRs) that, upon sensing, induce 
the expression of type I interferons (IFNs) and other antiviral genes1, 2. Among the PRRs, 
RIG-I (encoded by DDX58) is a key sensor for detection of RNA virus infection that 
recognizes virus-derived double-stranded RNA (dsRNA) in the host cell cytoplasm and 
initiates signaling cascades leading to the activation of antiviral defense pathways. The C-
terminal domain of RIG-I recognizes and binds the 5′-end of the RNA ligand, which is 
followed by RNA binding to the RIG-I central helicase domain. RNA binding triggers a 
conformational change in RIG-I that allows for the release of its N-terminal caspase 
activation and recruitment domains (CARDs) and binding to mitochondrial antiviral-
signaling protein (MAVS)3, 4.
Two well-characterized features of RIG-I ligands are a 5′-triphosphate moiety and adjacent 
base-paired stretches of at least 10–19 bp5, 6, 7, as found in the genomes or replication 
intermediates of several RNA viruses8, 9, 10. Furthermore, viral RNAs bearing 5′-
diphosphates as well as poly-U/UC sequences are also recognized by RIG-I11, 12, indicating 
that RIG-I is capable of recognizing a diverse group of viral RNA species.
In addition to its role in the detection of RNA viruses, evidence is accumulating that RIG-I 
plays a critical role in mounting an innate immune response to several DNA viruses, 
including herpesviruses and adenoviruses12, 13, 14. For the detection of EBV-derived DNA, 
RNA polymerase III (Pol III) has been shown to convert poly(dA:dT) into short 5′-
triphosphate-containing RNAs that are recognizable by RIG-I, suggesting that Pol III acts 
upstream of RIG-I by producing RIG-I ligands through conversion of dsDNA12, 13. 
However, physiological ligands recognized by RIG-I during DNA virus infection have not 
been identified.
Here we show that HSV-1 infection leads to the nuclear-to-cytoplasmic relocalization and 
exposure of cellular 5S ribosomal RNA pseudogene 141 (RNA5SP141) transcripts, allowing 
their recognition by RIG-I. RNA5SP141 is critical for antiviral cytokine induction in 
response to HSV-1 and EBV, as well as the RNA virus IAV. Our study provides evidence 
that RIG-I–mediated immunity can be triggered by viral perturbation of the life cycle of 
host-derived RNAs.
RESULTS
Temporal role of RIG-I and DNA receptors in sensing HSV-1
Although recent evidence indicates that RIG-I plays an important role in the antiviral 
defense to DNA viruses, its contribution relative to other key intracellular sensors of DNA 
virus infection, in particular cyclic GMP-AMP synthase15 (cGAS) and IFN-inducible 
protein 16 (IFI16)16, has not been determined. We hypothesized that RIG-I and DNA 
sensors may play temporally distinct roles during DNA virus infection, possibly due to the 
emergence of specific pathogen-associated molecular patterns (PAMPs) recognized by these 
sensors at different times during infection. To test this hypothesis, we individually depleted 
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endogenous RIG-I, cGAS, and IFI16 using small interfering RNA (siRNA) in primary 
normal human lung fibroblasts (NHLFs), followed by infection with HSV-1, a DNA virus of 
the Herpesviridae family. Knockdown of endogenous RIG-I had no significant effect on 
IFNB1 and TNF mRNA amounts at early time points after HSV-1 infection (6 hours post-
infection (hpi)), but substantially reduced cytokine expression at a late time point (16 hpi) 
(Supplementary Fig. 1a). In contrast, silencing of cGAS impaired cytokine induction at both 
time points, while knockdown of IFI16 reduced TNF induction at 6 hpi but not 16 hpi. To 
corroborate the role of RIG-I in the detection of HSV-1, we assessed HSV-1-mediated 
upregulation of selected cytokines, chemokines and IFN-stimulated genes (ISGs) in RIG-I–
deficient mouse embryonic fibroblasts (Ddx58−/− MEFs) (Supplementary Fig. 1b). 
Compared to wild-type MEFs (Ddx58+/+), induction of antiviral and proinflammatory genes 
in Ddx58−/− MEFs was severely attenuated, particularly at late times post-infection. 
Together, these results indicated that cGAS, IFI16 and RIG-I contribute to HSV-1 sensing in 
a temporally distinct manner, with RIG-I acting specifically at later time points during 
infection when potential immunostimulatory RNAs may emerge.
Binding of host RNAs to RIG-I during HSV-1 infection
To identify the physiological RNA species that are recognized by RIG-I during HSV-1 
infection, we purified the RNAs that co-immunoprecipitated with FLAG-tagged RIG-I in 
transfected human embryonic kidney (HEK) 293T cells that had been infected with a 
recombinant HSV-1 (HSV-1mut) containing a mutation in the viral serine/threonine protein 
kinase US3 that abolishes its catalytic activity, as the viral kinase is known to antagonize 
type I IFN responses17 (Fig. 1a). As controls, RNA species bound to FLAG-RIG-I in 
uninfected cells and RNA bound to FLAG-GFP from both HSV-1mut-infected and uninfected 
cells were also purified. The RIG-I-bound RNA, but not the GFP-bound RNA from 
HSV-1mut-infected cells, induced robust activation of an IFN-sensitive response element 
(ISRE)-driven promoter, albeit less efficiently than RNA co-immunoprecipitated with 
FLAG-RIG-I from HEK 293T cells infected with Sendai virus (SeV), an RNA virus that 
potently activates RIG-I and served as positive control (Fig. 1b and Supplementary Fig. 2a). 
In contrast, the immunostimulatory activity of RIG-I–bound RNAs extracted from 
uninfected cells was minimal, indicating the emergence of RIG-I ligands during HSV-1 
infection. Next, RIG-I–bound RNA and total RNA extracted from uninfected and HSV-1mut-
infected cells were analyzed by RNAseq, and the resulting sequences were mapped to both 
the HSV-1 and human genomes. This analysis revealed that several human transcripts were 
highly enriched in the RIG-I–bound fraction from infected cells; in contrast, the enrichment 
of viral sequences was low (Fig. 1c), suggesting that the RIG-I–stimulatory RNA species 
that emerge during HSV-1 infection are host- rather than virus-derived. The cellular 
transcripts that were most abundant in the RIG-I fraction were predominantly non-coding 
RNAs from different subclasses as well as some coding RNAs (Fig. 1d,e). Among the top 
ten RNAs that bound to RIG-I specifically in HSV-1mut-infected cells were three 5S 
ribosomal RNA pseudogene transcripts (RNA5SP), of which 5S rRNA pseudogene 141 
(RNA5SP141) was the most substantially enriched RNA in the RIG-I-bound fraction (Fig. 
1e). qRT-PCR analysis using primers designed to target unique regions in RNA5SP141 that 
are absent in the parental 5S rRNA confirmed that RNA5SP141 was highly enriched in RIG-
I precipitates specifically from HSV-1mut-infected, but not uninfected cells or GFP 
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precipitates from either condition (Fig. 1f). RNA5SP141 was also highly enriched in RIG-I 
precipitates from cells infected with wild-type HSV-1 (HSV-1WT) (Fig. 1f). Importantly, 
endogenous RNA5SP141 purified from total cellular RNA using specific locked nucleic acid 
(LNA) antisense oligonucleotides detectably triggered IFNB1 mRNA induction when 
transfected into NHLFs (Supplementary Fig. 2b,c) when compared to RNA purified with 
‘scrambled’ LNA antisense oligos, or purified RNU1-1 RNA, which served as an additional 
control, further substantiating a role for RNA5SP141 in innate immune activation.
RNA5SP141 is a direct ligand of RIG-I
We next sought to examine if RNA5SP141 is a direct and specific ligand of RIG-I. Since 
very little is known about the expression and function of RNA5SP transcripts, we inspected 
their parent gene, 5S rRNA, for insight into how the transcribed pseudogenes may serve as 
RIG-I agonists. 5S rRNA is a 120 nucleotide Pol III transcript with a highly stable secondary 
structure composed of helices and hairpin loops organized in a three-helix junction18. 
Structure prediction suggests that, like the parental 5S rRNA, RNA5SP141 has extensive 
base-pairing throughout and particularly at the 5′-end (Supplementary Fig. 3a). We 
hypothesized that these double-stranded regions, along with the 5′-triphosphate moiety that 
is characteristic of Pol III transcripts, may provide the molecular basis for RNA5SP141 
recognition by RIG-I and stimulation of innate immunity. Indeed, in vitro–transcribed 
RNA5SP141 robustly upregulated IFNB1 mRNA in both HEK 293T and primary NHLF 
cells, and also induced the expression of the proinflammatory cytokine TNF and the ISGs 
ISG15 and DDX58 (Fig. 2a and Supplementary Fig. 3b–d). The cytokine and ISG induction 
by RNA5SP141 was comparable to, or even higher than, the induction triggered by a 58-
nucleotide rabies virus leader (RABVLe) in vitro transcript, which was previously shown to 
activate RIG-I5, 19, while a 59-nucleotide RNA derived from an internal rabies virus 
sequence (previously called ‘RV2024-2080’20 and hereafter termed ‘RABVINT’), which 
served as negative control, was not immunostimulatory (Fig. 2a). In agreement with these 
observations, RNA5SP141 transfection induced the dimerization of interferon regulatory 
factor 3 (IRF3), a key transcription factor downstream of RIG-I and also other PRRs21, to 
levels comparable to those after SeV infection or RABVLe transfection (Fig. 2b). Depletion 
of RIG-I, but not MDA5, using specific siRNAs severely impaired the ability of 
RNA5SP141 to elicit an IFN-β response, indicating that RNA5SP141 specifically activates 
RIG-I (Supplementary Fig. 4a). In a complementary approach and to rule out the possibility 
that potential dsRNA byproducts generated during in vitro transcription triggered RIG-I 
activation, we also generated a DNA construct encoding the RNA5SP141 sequence under 
the Pol III promoter U6 and tested its immunostimulatory activity (Fig. 2c). U6-expressed 
RNA5SP141 triggered robust ISRE-promoter activation, and this activity was abrogated 
when endogenous RIG-I was depleted, while it was unchanged upon knockdown of MDA5 
(Fig. 2c). Silencing of MDA5, however, reduced ISRE-promoter activation triggered by 
transfection of high molecular weight (HMW) polyinosine-polycytidylic acid [poly(I:C)], an 
MDA5 agonist which served as control. Furthermore, transfection of a DNA construct 
encoding U6-expressed RABVINT served as an additional control in this assay to confirm 
that DNA transfection itself did not induce activation of the ISRE-promoter in HEK 293T 
cells, which are known to be defective in cGAS-STING signaling15 (Fig. 2c). Similarly, U6-
expressed RNA5SP141, but not RABVINT, robustly induced IFNB1 transcripts in NHLFs, 
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and silencing endogenous RIG-I, but not MDA5, blunted IFNB1 induction triggered by U6-
expressed RNA5SP141 (Fig. 2d), further supporting that RNA5SP141 elicits cytokine 
responses via RIG-I. Phosphatase treatment of RNA5SP141 to remove the 5′-triphosphate 
group, a well-defined feature of RIG-I ligands5, 6, abrogated its ability to stimulate ISRE-
promoter activation (Fig. 2e). Finally, to confirm that RNA5SP141 directly interacts with 
and activates RIG-I, we performed an ATP hydrolysis assay using in vitro–transcribed 
RNA5SP141 and purified RIG-I protein. Upon binding, RIG-I agonists activate the ATPase 
of the central helicase domain of RIG-I22, and we found that RNA5SP141 did indeed 
efficiently induce RIG-I ATPase activity to a comparable extent as that by RABVLe (Fig. 
2f). Collectively, these findings demonstrate that RNA5SP141 is a direct ligand of RIG-I.
Subcellular relocalization of RNA5SP141 by HSV-1
To define the mechanism by which RNA5SP141 transcripts are recognized by RIG-I in 
HSV-1-infected cells but not uninfected cells, we first considered the possibility that HSV-1 
infection leads to changes in RNA5SP141 gene expression, thereby facilitating its sensing 
by RIG-I. While HSV-1 is known for its ability to downregulate most host mRNAs, a 
phenomenon termed virus-induced host shutoff, other cellular RNAs are not downregulated 
(e.g., tRNAs and rRNAs), or are instead upregulated (e.g., proinflammatory cytokine 
transcripts)23. Both RNAseq and qRT-PCR analysis showed that RNA5SP141 is upregulated 
~2- to 3-fold in HSV-1-infected cells compared to uninfected cells; in contrast most host 
RNAs were downregulated during HSV-1 infection, consistent with previous reports23 
(Supplementary Fig. 4a,b). However, as RNA5SP141 was highly enriched in the RIG-I–
bound fraction from HSV-1–infected cells, we considered the possibility that additional 
changes in the distribution or availability of RNA5SP141 must occur during HSV-1 infection 
that enable RNA5SP141 detection by RIG-I.
While little information exists about the life cycle of RNA5SP transcripts, it has been 
established that the parental 5S rRNA is transcribed in the nucleoplasm and then either 
imported into the nucleolus for ribosome biogenesis, or exported to the cytoplasm and 
mitochondria24. We hypothesized that RNA5SP141 may follow a similar pattern of 
transcription and transport that, when perturbed by HSV-1, allows sensing of RNA5SP141 
by RIG-I in the cytoplasm. As HSV-1 replication and egress from the cell nucleus are known 
to remodel and disrupt the nuclear architecture25, we tested whether HSV-1 infection 
triggers nuclear-to-cytoplasmic relocalization of RNA5SP141. To this end, we performed a 
fractionation assay of uninfected or HSV-1–infected HEK 293T cells and compared the 
abundance of RNA5SP141 in the cytoplasmic and nuclear fractions. We observed that, while 
RNA5SP141 was predominately nuclear in uninfected cells, it was predominantly 
cytoplasmic in HSV-1-infected cells (Fig. 3a). As compared to RNA5SP141, the 
cytoplasmic abundance of RNU2-1, MALAT1, and NEAT1, which are well-defined nuclear 
RNAs26, were only marginally increased following HSV-1 infection. Furthermore, 
RNA5SP141 localization remained predominantly nuclear in cells infected with SeV (Fig. 
3b), suggesting that the induction of RNA5SP141 relocalization may be specific for 
infection with herpesviruses, or perhaps more generally, viruses that replicate in the nucleus. 
Collectively, these data showed that HSV-1 infection leads to increased cytoplasmic 
localization of RNA5SP141.
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RNA5SP141-binding protein depletion activates RIG-I
When 5S rRNA is present in the cytoplasm, it is normally tightly associated with proteins 
that facilitate its subcellular transport, increase its stability, or mediate its function as part of 
the large ribosomal subunit24. At least three major cytoplasmic 5S rRNA-binding proteins 
have been identified that include ribosomal protein L5 (RPL5), which associates with 5S 
rRNA to form 5S ribonucleoprotein particles24, and mitochondrial ribosomal protein L18 
(MRPL18) and thiosulphate-sulphur transferase (TST; also called rhodanese), both of which 
facilitate the import of cytoplasmic 5S rRNA into mitochondria27. We hypothesized that, as 
with parental 5S rRNA, RNA5SP141 is associated with these proteins when present in the 
cytoplasm. Under normal conditions the 5S rRNA-interacting proteins may ‘shield’ it from 
the immune surveillance apparatus, whereas HSV-1-mediated shutoff of their synthesis may 
liberate RNA5SP141 for recognition by RIG-I. To address this hypothesis, we tested the 
following: whether RNA5SP141 also complexes with 5S rRNA-binding proteins; HSV-1 
downregulates the abundance of 5S rRNA-binding proteins; and downregulation of these 
proteins increases RNA5SP141-RIG-I binding and thereby IFN induction. Co-
immunoprecipitation showed that RNA5SP141, like the parental 5S rRNA, bound to RPL5, 
MRPL18, and TST, although with different binding affinities (Fig. 4a). The abundance of 
mRNAs encoding 5S rRNA-binding proteins was significantly downregulated in HSV-1–
infected cells compared to uninfected cells (Fig. 4b,c), and the corresponding protein 
abundance of MRPL18 and TST were also reduced over the course of HSV-1WT infection 
(Fig. 4d, right). In contrast, the abundance of MRPL18 and TST proteins were not reduced 
in cells infected with a recombinant HSV-1 with a deletion in the gene encoding the virion 
host shutoff (vhs) protein (HSV-1Δvhs), an mRNA-specific RNase that plays a major role in 
HSV-1–induced host translational shutoff28 (Fig. 4d, left). Notably, despite downregulation 
of RPL5 transcripts upon HSV-1WT infection, we observed that RPL5 protein abundance 
was not reduced by HSV-1WT or HSV-1Δvhs infection, which is consistent with previous 
observations that ribosomal proteins are known to persist during HSV-1 infection despite 
viral shutoff mechanisms29. RNA5SP141 bound to RIG-I efficiently during infection with 
HSV-1WT, but not HSV-1Δvhs (Fig. 4e), suggesting that virus-induced downregulation of 
MRPL18 and/or TST proteins leads to the unshielding of RNA5SP141 transcripts, thereby 
allowing recognition by RIG-I and activation of innate immunity. In support of this, IFNB1 
transcripts induced by HSV-1Δvhs were lower than those induced by HSV-1WT infection 
(Fig. 4f). However, the phenomenon of higher cytokine induction by infection with 
HSV-1WT, as compared to HSV-1Δvhs, was not generally applicable, as the induction of the 
proinflammatory cytokine transcripts IL6 and IL8, which are known to be direct targets of 
vhs-mediated degradation30, was repressed in HSV-1WT-infected cells (Supplementary Fig. 
4d,e). To further test the role of 5S rRNA-interaction proteins in RNA5SP141-induced 
innate signaling, we used siRNAs to individually deplete endogenous RPL5, MRPL18, and 
TST, thereby mimicking the effects of HSV-1 infection (Fig. 4g). Depletion of MRPL18 or 
TST markedly enhanced IFNB1 mRNA abundance triggered by RNA5SP141 transfection 
but did not affect the response in mock-transfected cells. In contrast, depletion of RPL5 had 
no effect on RNA5SP141-induced IFNB1 mRNA expression. Inversely, ectopic expression 
of MRPL18 or TST, but not RPL5, dampened IFN-β promoter activation induced by 
RNA5SP141 in a dose-dependent manner (Fig. 4h), suggesting that the interaction of 
RNA5SP141 with MRPL18 and TST prevents RIG-I-dependent cytokine induction. These 
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findings support a model in which RNA5SP141 transcripts are mislocalized to the cytoplasm 
during HSV-1 infection, and virus-mediated downregulation of MLRP18 and TST allows 
access of RIG-I to these host-encoded transcripts, resulting in activation of innate immunity.
RNA5SP141-mediated cytokine response to HSV-1 and EBV
To determine the relevance of RNA5SP141 in eliciting an antiviral response to HSV-1 
infection, we performed siRNA knockdown of RNA5SP141 in NHLF cells and analyzed 
IFNB1 and TNF transcripts in response to HSV-1 infection (Fig. 5a and Supplementary 
Figure 5a). As compared to cells transfected with non-targeting control siRNA, expression 
of HSV-1-triggered IFNB1 and TNF mRNA in RNA5SP141-depleted cells were profoundly 
reduced and similar to that in RIG-I–depleted cells. Importantly, depletion of RNA5SP141 
had no effect on IFNB1 mRNA triggered by transfection of RABVLe or HMW-poly(I:C) 
(Fig. 5a), ruling out the possibility that silencing RNA5SP141 has a general inhibitory effect 
on IFNB1 induction. In support of this finding, silencing of RNA5SP141, unlike knockdown 
of RIG-I, had no effect on IFNB1 and TNF transcripts or secreted IFN-β or CCL5 protein 
triggered by infection with SeV (Fig. 5b and Supplementary Fig. 5b), which replicates in the 
cytoplasm and for which it has been well established that viral RNAs, in particular RNAs 
from defective interfering (DI) particles, trigger RIG-I activation9, 31.
We next used two different LNA gapmers, each with a different targeting sequence than the 
siRNA used in our experiments, to deplete endogenous RNA5SP141. As a control, we also 
used two gapmers to deplete endogenous RIG-I (Supplementary Fig. 6). Consistent with our 
siRNA results, gapmer-mediated depletion of either RNA5SP141 or RIG-I strongly reduced 
cytokine induction in response to HSV-1 (Fig. 5c). In contrast, gapmer-mediated knockdown 
of RNA5SP141 had no effect on SeV-induced IFNB1 transcripts, while RIG-I depletion 
abolished IFNB1 induction by SeV as expected (Fig 5d).
We next asked whether RNA5SP141 also serves as a RIG-I ligand during infection by other 
DNA viruses. EBV is a member of the Gammaherpesvirinae subfamily that also replicates in 
the nucleus and exhibits a strong host shutoff phenotype during lytic infection23. Using 
gastric adenocarcinoma cells harboring latent EBV episomes (AGS-EBV), in which EBV 
lytic replication can be induced by treatment with sodium butyrate (NaB), we found that 
EBV reactivation led to strong upregulation of TNF, IL6, and IL8 transcripts, but not IFNB1 
mRNA (Supplementary Fig. 7). Consistent with previous reports indicating that RIG-I plays 
a role in EBV detection12, 13, knockdown of endogenous RIG-I markedly reduced TNF 
induction upon EBV reactivation in AGS-EBV cells, while depletion of MDA5 had a 
moderate effect (Fig. 5e). Furthermore, siRNA-mediated silencing of RNA5SP141 resulted 
in profound reduction of TNF induction in response to EBV reactivation, similarly to RIG-I 
knockdown (Fig. 5e), suggesting that RIG-I activation by EBV is predominantly mediated 
by RNA5SP141 in these cells. Silencing of RIG-I or RNA5SP141 also strongly reduced IL6 
and IL8 mRNA as well as interleukin 8 (IL-8) protein secretion upon EBV reactivation (Fig. 
5f,g). Moreover, we observed that the RNA5SP141-interacting proteins MRPL18 and TST, 
but not RPL5, were downregulated upon EBV reactivation (Fig. 5h), suggesting that 
recognition of RNA5SP141 by RIG-I is triggered by EBV-mediated unshielding of 
RNA5SP141.
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Unlike most RNA viruses, IAV and other members of the family Orthomyxoviridae replicate 
in the host cell nucleus. RIG-I is the major sensor of IAV infection in mammalian cells, and 
recognizes IAV genomes and RNA derived from DI particles8, 9. We therefore asked whether 
RNA5SP141 also contributes to induction of antiviral immunity in the case of IAV infection. 
siRNA-mediated knockdown of RNA5SP141 markedly reduced the amount of IFNB1, 
IFIT2, and CCL5 transcripts induced by IAV in both NHLFs and HEK 293T (Fig. 6a–c and 
Supplementary Fig. 8a–c). Similarly, depletion of RNA5SP141 decreased IFNB1 induction 
in response to IAVΔNS1, a recombinant virus that lacks NS1 and is therefore unable to 
efficiently antagonize innate signaling32, 33 (Supplementary Fig. 8d).
Consistent with our results on cytokine transcripts, siRNA-mediated silencing of 
RNA5SP141 also reduced the secretion of IFN-β and CCL5 upon IAV infection (Fig. 6d). 
Similarly, gapmer-mediated depletion of RNA5SP141 also led to strongly reduced IFNB1, 
IFIT1 and ISG15 transcripts in response to IAV, although less efficiently than depletion of 
RIG-I (Fig. 6e,f). In support of our model that virus-induced downregulation of 
RNA5SP141-binding proteins mediates unmasking of RNA5SP141, we also observed 
reduced amounts of TST and MRPL18, as well as RPL5, in IAV-infected cells as compared 
to uninfected cells (Fig. 6g). These data indicate that, during IAV infection, both virus-
derived RNAs8, 9 and host-derived RNA5SP141 contribute to efficient detection of IAV by 
RIG-I. As IAV-induced nuclear rearrangements and host shutoff effects differ substantially 
from those of herpesviruses, the molecular mechanisms that allow for RNA5SP141 sensing 
by RIG-I during IAV infection will require further study.
Collectively, we find that RNA5SP141 is important for the RIG-I–mediated immune 
response to DNA viruses and at least one RNA virus (IAV) that replicates in the nucleus. 
However, the full range and characteristics of viruses that trigger RNA5SP141-mediated 
activation of RIG-I remain to be determined.
DISCUSSION
Intracellular innate immune sensors are known to function by recognizing specific molecular 
signatures that are unique to viral pathogens. The presence of 5′-triphosphate-RNAs in the 
cytoplasm is believed to serve as a means by which RIG-I discriminates between ‘self’ and 
‘non-self’. In contrast to viral 5′-triphosphate-containing RNAs, most mature host RNAs are 
modified (e.g., tRNAs which bear 5′-monophosphates) or capped (e.g., mRNAs) after their 
export from the nucleus to the cytoplasm. However, several small RNAs bearing a 5′-
triphosphate group (e.g. Pol III transcripts) are also present in the host cell cytoplasm, but it 
has been unknown whether these endogenous RNA species can activate RIG-I. This study 
provides evidence that innate immunity can be triggered by signals that follow pathogen 
assault and originate from the host itself. Furthermore, our findings that RNA5SP141, a Pol 
III transcript, activates RIG-I during HSV-1 and EBV infection confirm previous reports 
showing that the Pol-III-RIG-I axis is important for activation of the innate immune 
response to DNA viruses12, 13. Our work proposes a model in which the recognition of 
immunostimulatory cellular 5S rRNA pseudogene transcripts is normally prevented through 
association with specific interacting proteins. However, alterations in nuclear envelope 
integrity and shutoff of host protein synthesis caused by herpesviral infection allow for 
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innate recognition of these pseudogene transcripts. While virus-induced shutoff of host 
protein synthesis is believed to promote virus replication by reducing the competition 
between viral and host mRNAs for nuclear export and the cellular translational machinery, 
our data suggest that this strategy also makes the virus vulnerable to detection by the innate 
immune system. RNA5SP141 was also critical for initiation of RIG-I-mediated cytokine 
responses to IAV, which is unique amongst RNA viruses as it replicates in the nucleus. Thus, 
viruses that both inhibit host protein synthesis and disrupt nuclear integrity may be more 
likely to inadvertently expose host-derived immunostimulatory RNAs, but future studies are 
needed to determine the relevance of RNA5SP141 in eliciting innate immunity to other 
viruses. Additionally, although our study revealed a prominent role for RNA5SP141 in 
activating RIG-I-mediated immunity, it is possible that other 5S rRNA pseudogene 
transcripts may also contribute to innate immune activation. Moreover, other endogenous 
RIG-I ligands that have recently been described include RNase L cleavage products34 and 
exosomal 7SL RNA35. These studies and ours further strengthen the concept of 
proinflammatory signal activation through host-derived RNAs.
Interestingly, while in vitro experiments have demonstrated that blunt-ended 5′-triphosphate 
dsRNAs activate RIG-I most strongly36, structure predictions suggest that RNA5SP141, 
which has the characteristic RIG-I agonist features 5′-triphosphate moiety and dsRNA 
stretches, is not blunt-ended, similar to endogenous RNAse L cleavage products34 and 
exosomal 7SL RNA35. This suggests that endogenous RIG-I ligands do not strictly adhere to 
the criteria of ‘classical’ RIG-I ligands and extends the diverse group of RNA species that 
RIG-I recognizes.
Recent studies linked aberrant sensing of intracellular RNA or DNA to several 
proinflammatory or autoimmune disorders. Conceptually, these disorders arise from single-
nucleotide polymorphisms in innate sensing or signaling molecules, or enzymes that degrade 
viral nucleic acids, thereby leading to accumulation of stimulatory RNA or DNA ligands37. 
While our study reveals that the recognition of cellular RNA5SP141 by RIG-I is part of the 
antiviral defense program, it is conceivable that this mechanism of ‘self’ recognition could 
also be implicated in the loss of immune homeostasis due to other causes of cellular 
disturbance leading to RNA5SP141 exposure. Conversely, small inhibitors designed to 
disrupt the interaction of RNA5SP141 and MRPL18 or TST may be useful for stimulating 
antiviral immunity.
ONLINE METHODS
Cell culture and viruses
HEK 293T (ATCC), Vero (ATCC), NHLF (Clonetics), RIG-I WT and deficient MEFs38, as 
well as HEK 293T ISRE-luciferase reporter cells39 were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM 
GlutaMAX (Gibco), and 1% (v/v) penicillin-streptomycin (Gibco) under standard tissue 
culture conditions. AGS-EBV cells40 (generously provided by N. Raab-Traub, UNC-Chapel 
Hill) were cultured in Ham’s F12 medium supplemented with 10% (v/v) FBS, 2 mM 
GlutaMAX (Gibco), 1% (v/v) penicillin-streptomycin, and 500 µg/ml G418 (Gibco). 
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Reactivation of EBV in AGS-EBV cells was induced by treatment with 2.5 mM sodium 
butyrate (NaB) (Sigma) dissolved in sterile water.
Cell lines from ATCC or Clonetics were authenticated by the vendors and were not validated 
further in our laboratory. Cell lines that were obtained and validated by other groups were 
not further authenticated. All cell lines have been regularly tested for potential mycoplasma 
contamination by PCR.
A US3 K220A HSV-1 mutant (HSV-1mut) was generated using a bacterial artificial 
chromosome (BAC) clone of HSV-1 strain (F) (pYEbac102; kindly provided by Y. 
Kawaguchi, University of Tokyo, Japan). To facilitate detection of infected cells, 
pYEbac102 was modified by insertion of the egfp (enhanced green fluorescent protein) gene 
into mini-F vector sequences, resulting in the pYEbac102-G construct that was used for 
further manipulation. Expression of EGFP was driven by the human cytomegalovirus 
(HCMV) immediate-early (IE) promoter. En passant mutagenesis41 was performed to 
introduce a mutation at amino acid residue 220 of the US3 protein kinase where the original 
lysine (K) was substituted with alanine (A), leading to the BAC pYEbac102-K220A–G 
construct. The following primers were used to amplify the PCR product that allowed for 
mutagenesis to occur: (forward: 5′-
TGACAGCAGCCACCCAGATTACCCCCAACGGGTAATCGTG GCG 
GCGGGGTGGTACACGAGCACTAGGGATAACAGGGTAATCGAT-3′; reverse: 5′-
GCAGTCGCGCCTCGTGGCTCGTGCTCGTGTACCACCCCGC CGC 
CACGATTACCCGTTGGGGGTCCAGTGTTACAACCAATTAACC-3′; (nucleotides in 
italics and bold represent the desired mutation). After confirmation of the constructs by 
restriction fragment length polymorphism (RFLP) and DNA sequencing (LGC Genomics), 1 
µg each of purified BAC DNA was transfected into Vero cells at 90% confluency using 
polyethylenimine (PEI; Polysciences) At 72 h post-transfection, when visible fluorescent 
plaques appeared, the respective virus mutant was reconstituted and harvested by 3 cycles of 
freeze-thaw.
The mutant HSV-1Δvhs and its revertant virus were generously provided by B. Roizman 
(University of Chicago) and have been described previously42. Sendai virus (SeV, Cantell 
strain) was purchased from Charles River Laboratories. Influenza A/Puerto Rico/8/1934 and 
ΔNS1 recombinant virus were generously provided by A. Garcia-Sastre (Mount Sinai).
DNA constructs and transfections
FLAG-RIG-I and FLAG-GFP, cloned into the pcDNA5 FRT/TO vector, have been 
previously described10. pCMV6-Entry plasmids encoding Myc-DDK-tagged human RPL5, 
MRPL18, and TST were purchased from OriGene. The DNA construct encoding U6 
promoter-expressed RNA5SP141 was generated by PCR using the following forward (F) 
and reverse (R) primers: F1 primer: 5′-
TGGAAAGGACGAAACACCGTCTACGGCCATACCACCCTGAACGCGCCCGATCTCG
TC-3′; F2 primer: 5′-
CGCGCCCGATCTCGTCTGATCTCGGAAGCTAAGCAGGGTTGGGCCTGGTTAGTAC
TTGGATGGGAGAAATACATCCAAAAACACGATGACTCACATG-3′; R primer: 5′-
CATGTGAGTCATCGTGTTTTTGGATG-3′. The DNA construct encoding U6 promoter-
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expressed RABVINT was generated using the following F and R primers: F1 primer: 5′-
TGGAAAGGACGAAACACCGGGCCAGGATGGCGGCTCAAACTGCTTCTGGCCCTC
CAGCCCTTGAATGGTCGGCCACC-3′; R primer: 5′-
GGTGGCCGACCATTCAAGGGCT-3′.
Transient transfection of cells was performed using calcium phosphate (Clontech), linear 
polyethylenimine (PEI (Polysciences, Inc.) at 1 mg/ml in 10 mM Tris pH 6.8), 
Lipofectamine and Plus reagent or Lipofectamine 2000 (both Life Technologies), according 
to the manufacturer’s instructions.
Antibodies and other reagents
The following antibodies were used for immunoblot analysis: anti-FLAG (1:2000, M2, 
Sigma), anti-Lamin A/C (1:2000, E-1, Santa Cruz), anti-Tubulin (1:2000, 2144, Cell 
Signaling), anti-β-Actin (1:5000, A1978, Sigma), anti-ICP8 (1:10,000, kindly provided by 
David Knipe (Harvard University)), anti-RPL5 (1:1000, GTX101821, GeneTex), anti-
MRPL18 (1:500, ab67844, Abcam), anti-TST (1:200, H-75, Santa Cruz), anti-IRF3 (1:500, 
FL-425, Santa Cruz), anti-RIG-I (1:2000, Alme-1, Adipogen), anti-Sendai virus (1:1000, 
PD029, MBL), anti-EBV Ea-R p85 (1:500, 6G7, Santa Cruz), and anti-IAV NS1 (1:1000, 
NS1–23-1, Santa Cruz). Goat anti-mouse- or goat anti-rabbit-Horseradish Peroxidase (HRP) 
secondary antibodies (both 1:2000) were purchased from Cell Signaling (cat #7076S and 
#7074S, respectively).
Anti-FLAG (DYKDDDDK) magnetic beads for RNA co-IP were purchased from Origene or 
Clontech. Protease inhibitor cocktail used for RIG-I–RNA co-IP was purchased from Sigma 
(cat #4693132001), and protease inhibitor cocktail used for all other experiments was 
purchased from Sigma (cat #P2714-1BTL).
ELISA kits for IFN-β (PBL Assay Science #), IL-8 (R&D Systems #D8000C), and CCL5 
(Thermo Scientific #EHRNTS) were purchased and assays were performed according to the 
manufacturer’s instructions.
LyoVec-conjugated high molecular weight (HMW) poly(I:C) was purchased from Invivogen 
(cat #tlrl-piclv) and prepared according to the manufacturer’s instructions.
Large-scale co-immunoprecipitation of RNA-bound RIG-I from infected cells
HEK 293T cells (~ 2.5 ×106 cells per 100 mm dish, 1 dish per sample) were transfected with 
FLAG-RIG-I or FLAG-GFP (10 μg DNA per dish) using polyethylenimine. 24 h later, cells 
were infected with either HSV-1mut (MOI 300) or SeV (50 HAU/ml), or left uninfected. 
Cells were harvested 16 h later and lysed in Nonidet P-40 (NP-40) lysis buffer (50 mM 
HEPES, pH 7.4, 150 mM KCl, 1 mM Na3VO4, 0.5% (v/v) NP-40 and 0.5 mM Dithiothreitol 
(DTT, Sigma, cat #10197777001), supplemented with protease inhibitor (Sigma)) for 30 min 
at 4 °C. The lysates were cleared by centrifugation at 10,000 × g for 20 min at 4 °C. To co-
immunoprecipitate RNA-bound FLAG-RIG-I and FLAG-GFP, cleared lysates were mixed 
with a 50% slurry of anti-FLAG-conjugated magnetic beads (Origene or Clontech), and the 
binding reaction was incubated for 4 h at 4 °C. Precipitates were washed three times with 
NP-40 lysis buffer and two times with high-salt wash buffer (50 mM HEPES, pH 7.5, 300 
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mM KCl, 1 mM Na3VO4, 0.5% (v/v) NP-40, 0.5 mM DTT, supplemented with protease 
inhibitor [Sigma]), followed by incubation with proteinase K (New England Biolabs) at 
55 °C for 1 h. The RNA bound to FLAG-RIG-I or FLAG-GFP was extracted using phenol/
chloroform/isoamylalchohol (Amresco).
RNAseq analysis
RNA purified from FLAG-RIG-I or FLAG-GFP precipitates from mock-infected or 
HSV-1mut-infected HEK 293T cells, as well as their respective total RNA input samples 
were converted to a DNA library for sequencing, both performed at the Harvard 
Biopolymers Facility (Boston, MA). Up to 1000 ng total RNA was used in the Wafergen 
(formerly IntegenX) PrepX RNA-Seq Library Kit (cat #400039) and placed into the 
Wafergen Apollo, and run using a standard protocol. PCR was performed on samples using 
indexed primers according to Wafergen instructions and then cleaned using the Wafergen 
Apollo. The resulting samples were run on an Agilent 2200 Tape Station on a D1000 High 
Sensitivity Tape with ladder provided to assess the integrity and overall concentration of 
DNA. DNA libraries were run in a qPCR assay with SYBR green KAPA SYBR FAST 
Universal 2× qPCR Master Mix (Kapa Biosystems, cat #KK4602) and primers to the P5 and 
P7 regions of the adapters. Diluted PhiX was used for the standard curve to determine 
concentration. Libraries passing quality control were subjected to Illumina HiSeq 2500 
sequencing (Harvard Biopolymers Facility). A local Galaxy server was used to process the 
RNAseq data43. Raw sequence reads were quality trimmed using TRIM Galore! (Cutadapt44 
and FastQC wrapper45) and aligned to human herpesvirus 1 strain F (GenBank accession 
number GU734771, annotation converted using bp_genbank2gff3.pl) or human genome 
(hg38) using Tophat246 with settings that allow for zero mismatches in the final sequence 
alignment. HTSeq-count was used to calculate the induction of human transcripts, and the 
obtained results were normalized using total count normalization47. Furthermore, the RIG-I–
precipitate and GFP-precipitate counts were normalized to their respective input RNA. RIG-
I–specific transcript enrichment was calculated by dividing the normalized RIG-I-precipitate 
counts through the normalized GFP-precipitate counts using R scripts. The data from two 
biologically independent experiments were multiplied, and visualized in R48 using the 
ggplot2 package49.
Immunoblot analysis
Infected or transfected cells were lysed in NP-40 lysis buffer (50 mM HEPES pH 7.4, 150 
nM NaCl, 1% (v/v) NP-40, supplemented with protease inhibitor cocktail [Sigma]), 
followed by centrifugation at 10,000 × g for 20 min to remove insoluble material. Cleared 
lysates were resolved on 7%, 10%, or 12% Bis-Tris SDS-PAGE gels (pH 6.4), and 
subsequently transferred to a Polyvinylidene difluoride (PVDF) membrane (Bio-Rad) using 
a Trans-Blot SD (Bio-Rad). Membranes were blocked with 5% (w/v) non-fat dry milk 
(NFDM) in PBS for 1 h, and then probed with primary antibody in antibody dilution buffer 
(PBS supplemented with 0.05% (v/v) Tween-20 and 5% (w/v) NFDM) at the indicated 
dilutions (as described above) for either 1 h at ~18–23 °C, or at 4 °C overnight. Membranes 
were probed with goat anti-mouse- or goat anti-rabbit-HRP antibodies (Cell Signaling cat 
#7076S and #7074S, respectively) in antibody dilution buffer for 1 h at ~18–23 °C. Proteins 
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were visualized using an enhanced chemiluminescence reagent (Pierce) and detected by 
Fujifilm luminescent image analyzer LAS-4000 or Amersham Imager 600.
Native PAGE
HEK 293T cells, seeded into 6-well plates (~ 3 × 105 cells per well), were transfected with 
125 pmol of RABVLe or RNA5SP141 in vitro transcripts, or infected with SeV (50 HAU/
ml). 16 h later, cells were lysed by three cycles of freeze-thaw in NP-40 lysis buffer. Native 
PAGE was performed as previously described50.
Luciferase reporter assays
HEK 293T cells were seeded into 12-well plates (~ 1 × 105 cells per well). The next day, 
cells were transfected with 200 ng IFN-β luciferase construct51 and 300 ng β-galactosidase-
expressing pGK-β-gal52, along with 5–125 ng of the indicated constructs encoding 5S 
rRNA-interaction proteins, or empty vector, using Lipofectamine and Plus reagent (Life 
Technologies), according to the manufacturer’s instructions. 30 h later, cells were 
transfected with either no RNA or 10 pmol of in vitro-transcribed RNA5SP141 using 
Lipofectamine 2000 (Life Technologies), according to the manufacturer’s instructions. 16 h 
later, cells were harvested and lysates were subjected to luciferase and β-galactosidase 
activity assays (both Promega). Luciferase and β-galactosidase activity was measured using 
a BioTek Synergy Microplate Reader in 96-well plates using 10 μl and 25 μl of cell lysates, 
respectively. Luciferase activity was normalized to β-galactosidase values, and luciferase 
induction was calculated relative to mock-transfected samples, set as 1.
For ISRE-luciferase assays, HEK 293T ISRE-luciferase reporter cells were seeded into 12-
well plates (~ 1 × 105 cells per well) and transfected the next day with either 7 μl of RNA 
retrieved from RIG-I- or GFP-precipitates, or 500 fmol of CIP-treated or untreated in vitro– 
transcribed RABVLe or RNA5SP141, using Lipofectamine 2000 (Invitrogen). 16-18 h later 
(as indicated in the figure legends), cells were harvested and assayed for luciferase activity 
as described above. Fold induction of luciferase activity was calculated relative to mock-
transfected samples, set as 1.
siRNA-mediated knockdown
Transient knockdown of endogenous RIG-I, cGAS, IFI16, RPL5, MRPL18, and TST in 
HEK 293T and NHLF cells, seeded in 12-well plates (~ 1 × 105 cells per well), was 
achieved by transfection of gene-specific siGenome SMARTpool siRNAs (Dharmacon) with 
RNAiMAX transfection reagent (Invitrogen) according to the manufacturer’s instructions. 
As a control, non-targeting siRNA (Dharmacon, D-001206-14–20) was transfected. A final 
concentration of 150 nM per well was used. The following siRNAs were used: siRNAs 
targeting RIG-I (siGENOME SMARTpool M-012511-01–0010), cGAS (siGENOME 
SMARTpool M-015607-01–0005), IFI16 (siGENOME SMARTpool M-020004-01–0010), 
RPL5 (siGENOME SMARTpool M-013611-01–0005), MRPL18 (siGENOME SMARTpool 
M-017251-00–0005), and TST (siGENOME SMARTpool M-010120-00–0005) (all 
Dharmacon). At 46-48 h posttransfection (as indicated in the figure legends), knockdown 
efficiency was confirmed by analyzing the transcript abundance of the individual genes by 
qRT-PCR using specific primers (from IDT), or by determining their protein abundance by 
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immunoblot analysis. Transient knockdown of endogenous RNA5SP141 in HEK 293T, 
NHLF, and AGS-EBV cells was achieved by RNAiMAX transfection of custom-made 
siRNA with the sense sequence 5′-UGGGAGAAAUACAUCCAAAUU-3′ (Dharmacon). 
72 h post-transfection, knockdown efficiency was confirmed by analyzing the transcript 
levels of RNA5SP141 by qRT-PCR as described below.
In vitro RNA transcription
DNA templates for in vitro transcription of scrambled RNA, 5S rRNA, and RNA5SP141 
were generated by PCR with the primers listed in Supplementary Fig. 3b using KOD Hot 
Start Polymerase (EMD Millipore). DNA templates for in vitro transcription for control 
rabies virus leader sequence (RABVLe) and rabies virus internal sequence (RABVINT) were 
generated by annealing sense and antisense oligonucleotides as previously described20. RNA 
was synthesized using the MEGAshortscript in vitro transcription kit (Ambion) and purified 
using the MEGAclear transcription reaction purification kit (Ambion). RNA integrity was 
evaluated with the Agilent 2100 Bioanalyzer System using the Small RNA Analysis Kit 
(Agilent).
Phosphatase treatment of RNA
Calf intestinal alkaline phosphatase (CIP, New England Biolabs) was used according to the 
manufacturer’s instructions to treat RABVLe and RNA5SP141 in vitro transcripts for 3 h at 
37 °C. The RNA was purified using the MEGAclear kit (Ambion) and run on a 15% TBE-
Urea gel to validate RNA integrity. RNAs were subsequently tested for their 
immunostimulatory activity by ISRE-luciferase assays as described above.
Quantitative real-time PCR (qRT-PCR)
Total RNA was purified from cells using an RNA extraction kit (Omega Bio-tek) as per the 
manufacturer’s instructions. RNA quality was assessed using NanoDrop 2000. Equal 
amounts of RNA (25–500 ng) were used for an one-step qRT-PCR reaction using the 
SuperScript III Platinum One-Step qRT-PCR kit with ROX (Life Technologies) with 
commercially available FAM reporter dye primers (IDT) for the indicated genes. Gene 
expression was normalized to 18S (in experiments with HSV-1) or GAPDH (for all other 
experiments). Fold induction of each target gene relative to mock-infected or mock-treated 
cells was calculated using the Comparative CT Method (ΔΔCT Method).
For EBV BMRF1 transcript analysis, custom FAM reporter dye primers based on 
previously-described primer sequences53 were used (forward: 5′-
CAACACCGCACTGGAGAG-3′, reverse: 5′-GCCTGCTTCACTTTCTTGG-3′, probe: 5′-
AGGAAAAGGACATCGTCGGAGGC-3′) (IDT).
For RNA5SP141 transcript analysis, total RNA including small RNAs (<200 nt) were 
purified from cells using the miVana miRNA isolation kit (Life Technologies). Reverse 
transcription (RT) and qPCR were performed using the following TaqMan MicroRNA 
Assays which include a target-specific RT primer and a target-specific FAM reporter dye 
primer: RNA5SP141 (ThermoFisher cat #CSN1ESE) and let-7a (ThermoFisher cat 
#4440887). Equal amounts of RNA (10–100 ng) were reverse-transcribed using the TaqMan 
Chiang et al. Page 14
Nat Immunol. Author manuscript; available in PMC 2018 May 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
MicroRNA Reverse Transcription Kit (Applied Biosystems) with the target-specific RT 
primers. cDNA was then pre-amplified using the TaqMan PreAmp Master mix using the 
target-specific RT primers. qRT-PCR analysis was performed with the TaqMan Fast 
Advanced Master Mix (Applied Biosystems) using the target-specific TaqMan FAM reporter 
dye primers. Fold induction of RNA5SP141 relative to mock-infected or mock-treated cells 
was calculated using the ΔΔCT method, normalizing to let-7a, a miRNA that is maintained 
at stable levels during HSV-1 infection and serves as an internal control for miRNA 
abundance during infection54. All qRT-PCR assays were performed using a 7500 FAST RT-
PCR System (Applied Biosystems).
RIG-I ATPase hydrolysis assay
The RIG-I ATPase assay was performed as previously described55. Briefly, 250 nM of in 
vitro–transcribed RNA were incubated with 100 nM of RIG-I protein purified from insect 
cells (as previously described19) and 3 mM unlabeled ATP, including trace amounts of 
[γ-32P]ATP in EMSA buffer (5 mM MgCl, 50 mM KCl, 50 mM HEPES, 1 mM TCEP, 0.1 
mg/ml BSA, pH 7) for 0, 0.5, 1, 2, or 3 h at 37 °C. Free phosphate was separated from 
unhydrolyzed ATP by thin layer chromatography in TLC running buffer (1 M formic acid, 
0.5 M LiCl) on polyethyleneimine cellulose TLC plates (Sigma-Aldrich). [γ-32P]Pi and 
[γ-32P]ATP were detected using a phosphor-imaging system (GE Healthcare), quantified 
using ImageJ, and the percentage of hydrolyzed ATP for every time point was calculated. 
The average value of three replicates was calculated and average hydrolyzed ATP was 
plotted against time.
Cytoplasmic-nuclear fractionation assay
HEK 293T cells were seeded into 6-well plates (~3 × 105 cells per well). The next day, cells 
were infected with HSV-1 (MOI 1) or SeV (50 HA units/ml) for 16 h or left uninfected. 
Cells were fractionated using the Ambion PARIS fractionation kit according to the 
manufacturer’s instructions. Briefly, cell pellets were lysed in cell fractionation buffer on ice 
for 15 min and subjected to low-speed centrifugation to pellet nuclei. The supernatant 
(cytoplasmic fraction) was removed, and nuclear pellets were lysed in cell disruption buffer. 
Lysates from each fraction were divided into two equal samples and used for protein and 
RNA purification. Fractionated protein lysates were subjected to immunoblot analysis to 
assess the abundance of the nuclear protein lamin A/C and the cytoplasmic protein β-
tubulin. Fractionated RNA samples were subjected to qRT-PCR analysis to assess the 
abundance of nuclear RNA markers (MALAT1, NEAT1, and RNU2-1) and RNA5SP141 
transcripts in each fraction.
RNA pulldown assays
For purification of endogenous RNA5SP141 from total cellular RNA, 3′-biotinylated LNA 
oligos (Exiqon) with the following sequences were used: Scramble: 5′-
AGTTCCGTGCGTCGACTAGGA-3′/3BioTEG/; U1: 5′-
TACCACAAATTATGCAGTCGA-3′/3BioTEG/; and 5′-RNA5SP141: 
ATGTGAGTCATCGTGTTT-3′/3BioTEG/. For each sample, 50 µg of phenol-chloroform 
purified total cell RNA was incubated with 375 pmol LNA oligos for 30 min at ~ 18–23 °C. 
Next, MyONE Streptavidin C1 magnetic beads (ThermoFisher cat # 65002) were added to 
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the samples and incubated for 30 min at 25 °C. Beads were washed using buffers from the 
Dynabeads mRNA DIRECT Kit (Life Technologies cat #61011) according to the 
manufacturer’s instructions, and RNA was eluted from the beads by incubation at 65 °C for 
2 min.
For pull-down of 5S rRNA-interacting proteins, biotinylated scramble RNA, 5S rRNA, and 
RNA5SP141 (Supplementary Fig. 3b) were in vitro–transcribed using a Biotin-16-UTP 
RNA labeling mix (Roche), and RNA was purified using the MEGAclear transcription 
reaction purification kit (Ambion). RNA binding of 5S rRNA-interacting proteins was 
assessed by streptavidin pulldown (PD) as previously described56. Briefly, one to four 10-cm 
dishes of HEK 293T cells per sample were each transfected with 15 µg of FLAG-RPL5, 
FLAG-MRPL18, or FLAG-TST. Two days after transfection, cells were lysed in NP-40 lysis 
buffer supplemented with protease inhibitor (Sigma) and cleared by centrifugation at 10,000 
× g for 20 min. Cell lysates were incubated for 1 h at 22 °C with no RNA or 1 µg of 
biotinylated scramble RNA, 5S rRNA, or RNA5SP141. Samples were incubated with a 50% 
slurry of streptavidin agarose (Pierce) for 2 h at 4 °C and washed extensively with NP-40 
lysis buffer. WCLs and PD samples were subjected to immunoblot analysis to test for 
expression and binding of FLAG-tagged RPL5, MRPL18 and TST, respectively.
RNA secondary structure prediction
Prediction of RNA5SP141 secondary structure was performed using the Vienna RNAfold 
web server57 using standard settings.
LNA gapmer-mediated knockdown
Transient knockdown of endogenous RIG-I and RNA5SP141 in HEK 293T and NHLF cells, 
seeded in 24-well plates (~ 5 × 104 cells per well), was achieved by transfection of gene-
specific LNA gapmers (Exiqon) with Lipofectamine 3000 transfection reagent (Invitrogen) 
according to the manufacturer’s instructions at a final concentration of 50 nM LNA gapmer 
per well. Non-targeting scrambled antisense LNA gapmer (Exiqon, 300610) was transfected 
as a negative control. Custom-made LNA gapmers with the following sequences were used: 
RIG-I_1: 5′-CAAATGCGCAGAGGTC-3′, RIG-I_2: 5′-TCGGTTGGGATAATTC-3′, 
RNA5SP141_1: 5′-CATGTGAGTCATCGTG-3′, RNA5SP141_2: 5′-
TTTGGATGTATTTCTC-3′. At 72 h post-transfection, knockdown efficiency was 
confirmed by analyzing the transcript abundance of the individual genes by qRT-PCR using 
specific primers (IDT).
Statistical analysis
Unpaired two-tailed Student’s t tests were used to compare differences between two 
unpaired experimental groups in all cases. A P-value of <0.05 was considered statistically 
significant. Biological replicates consisted of individual cell cultures. No pre-specified effect 
size was assumed and in general 2 to 3 replicates for each condition was used, which was 
sufficient to demonstrate statistically significant differences.
A Life Sciences Reporting Summary for this paper is available.
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Figure 1. 
Endogenous non-coding RNAs co-immunoprecipitate with RIG-I during HSV-1 infection. 
(a) Schematic representation of the experimental setup for isolation and identification of 
RNAs from FLAG-RIG-I- or FLAG-GFP-precipitates. RNAseq, next-generation RNA 
sequencing. (b) ISRE-luciferase reporter activity in HEK 293T cells transfected for 18 h 
with 7 μl RNA from FLAG-RIG-I- or FLAG-GFP-precipitates from uninfected (Mock) or 
HSV-1mut-infected cells, isolated as described in (a). RNA from FLAG-RIG-I- or FLAG-
GFP-precipitates from HEK 293T cells infected with SeV (50 HAU/ml) served as control. 
Luciferase activity is presented as fold induction relative to the values for FLAG-GFP-
precipitates from uninfected cells, set to 1. (c) Relative enrichment of HSV-1–derived or 
human-derived transcripts in FLAG-RIG-I precipitates from HSV-1mut-infected cells, 
determined by RNAseq. Relative enrichment (log2) of transcripts was calculated by 
comparing the abundance of transcripts in FLAG-RIG-I precipitates to FLAG-GFP 
precipitates. Data are from two independent experiments. (d) Relative enrichment (log10) of 
human transcripts in FLAG-RIG-I precipitates from HSV-1mut-infected cells. The 9 most 
highly-enriched non-coding transcripts are shown. rRNA pseudogene (red); long non-coding 
RNA (lncRNA, green); small nucleolar RNA (snoRNA, yellow); small Cajal body-specific 
RNAs (scaRNA, purple). (e) Relative enrichment of the 10 most highly-enriched human 
transcripts (both non-coding and coding) in FLAG-RIG-I precipitates from HSV-1mut-
infected cells, as compared to uninfected cells. (f) Quantitative RT-PCR (qRT-PCR) analysis 
of RNA5SP141 transcripts from RNA isolated as described in (a) from HEK 293T cells 
transfected with FLAG-RIG-I or FLAG-GFP and infected with HSV-1WT or HSV-1mut (both 
MOI 1), or left uninfected (Mock). Data are representative of two independent experiments 
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(b,f; mean and s.d. of n = 3 technical replicates) or are from two independent experiments 
(c-e). **P < 0.005 (unpaired t-test).
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Figure 2. 
RNA5SP141 activates RIG-I. (a) qRT-PCR analysis of the indicated cytokine and ISG 
transcripts (vertical axes) in HEK 293T cells transfected with 200 fmol or 1 pmol in vitro-
transcribed RNA5SP141, or in vitro–transcribed RNA corresponding to the rabies virus 
leader sequence (RABVLe; positive control) or an internal rabies virus sequence (RABVINT; 
negative control). (b) Native PAGE and SDS-PAGE of lysates from HEK 293T cells 
transfected with 125 pmol of the indicated in vitro transcripts or infected with 50 HAU/ml 
SeV for 16 h, or left untreated (Mock). Endogenous IRF3 and actin were detected by 
immunoblot (IB) with anti-IRF3 and anti-actin, respectively. (c) Left: ISRE-luciferase 
reporter activity in HEK 293T cells transfected for 30 h with non-targeting control siRNA 
(si.Ctrl) or siRNAs targeting RIG-I or MDA5 (si.RIG-I or si.MDA5), and subsequently 
mock-transfected or transfected with 500 ng of a DNA construct encoding U6 promoter-
expressed RNA5SP141 or RABVINT (U6-5SP141 or U6-RABVINT) for 18 h. Treatment 
with 1 µg/ml HMW-poly(I:C) served as a control. Middle, right: Knockdown efficiency of 
endogenous RIG-I (DDX58) and MDA5 (IFIH1) was confirmed by qRT-PCR. (d) Left: 
qRT-PCR analysis of IFNB1 mRNA in NHLF cells that were transfected with the indicated 
siRNAs and U6 promoter-expressed DNA constructs as in (c). Treatment with 0.05 µg/mL 
HMW-poly(I:C) served as a control. Middle, right: Knockdown efficiency of endogenous 
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RIG-I (DDX58) and MDA5 (IFIH1) was confirmed by qRT-PCR. (e) ISRE-luciferase 
reporter activity in HEK 293T cells transfected for 18 h with 500 fmol in vitro–transcribed 
RNA5SP141 or RABVLe, which had been pre-treated with calf alkaline phosphate (CIP), or 
left untreated. (f) Quantification of hydrolyzed [γ-32P]ATP by RIG-I incubated for the 
indicated times with 250 nM of in vitro-transcribed RNA5SP141. Incubation of RIG-I with 
in vitro–transcribed RABVLe, or no RNA, served as positive and negative controls, 
respectively. Free phosphate was separated from unhydrolyzed ATP by thin layer 
chromatography, and the percentage of hydrolyzed ATP in each sample was calculated. Data 
are representative of two (b–f) or three (a) independent experiments (mean and s.d. of n = 2 
biological replicates in a, n = 3 biological replicates in b–e, n = 3 technical replicates in f).
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Figure 3. 
RNA5SP141 is relocalized from the nucleus to the cytoplasm during HSV-1 infection. (a) 
Left: Relative abundance of RNA5SP141 transcripts in the cytoplasmic and nuclear fractions 
of HEK 293T cells that were infected with HSV-1WT (MOI 1) for 16 h, or left uninfected 
(Mock), determined by cytoplasmic-nuclear fractionation assay and qRT-PCR. Analysis of 
the relative abundance of RNU2-1, MALAT1, and NEAT1 RNA served as controls. Right: 
IB analysis of Lamin A/C and β-Tubulin confirmed the purity of the nuclear and 
cytoplasmic fraction, respectively. IB analysis of whole cell lysates (WCL) with anti-HSV-1 
infected cell protein 8 (ICP8) and anti-actin served as infection and loading controls, 
respectively. Left margin, size in kilodaltons (kDa). (b) Left: Relative abundance of 
RNA5SP141 transcripts in the cytoplasmic and nuclear fractions of HEK 293T cells that 
were infected with SeV (50 HAU/ml) for 16 h or left uninfected (Mock), determined by 
fractionation assay and qRT-PCR analysis as described in (a). Right: IB analysis of 
cytoplasmic and nuclear fractions as in (a). IB analysis of WCL with anti-SeV confirmed 
efficient infection. Data are representative of two independent experiments.
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Figure 4. 
Downregulation of TST and MRPL18 by HSV-1 allows RIG-I activation. (a) Binding of 
biotinylated in vitro-transcribed RNA5SP141 to FLAG-tagged RPL5, MRPL18, and TST in 
transiently transfected HEK 293T cells, assessed by streptavidin pulldown (Strep-PD) and 
IB with anti-FLAG. WCLs were probed by IB with anti-FLAG and anti-actin. Biotinylated 
5S rRNA and a scrambled random RNA (Scrambled) served as positive and negative 
controls, respectively. (b) Relative mRNA expression of RPL5, MRPL18, and TST in HEK 
293T cells infected with HSV-1 (MOI 1) for 16 h as compared to uninfected cells, 
determined by RNAseq. Red boundaries represent ±2-fold change in gene expression. (c) 
qRT-PCR analysis of RPL5, MRPL18, and TST mRNA in HEK 293T cells infected with 
HSV-1 (MOI 1) for the indicated times. (d) IB analysis of endogenous RPL5, MRPL18, and 
TST proteins in the WCLs of HEK 293T cells infected with HSV-1WT (revertant) or 
HSV-1Δvhs (both MOI 10) for the indicated times. IB analysis of HSV-1 ICP8 and cellular 
Actin served as infection and loading controls, respectively. (e) HEK 293T cells were 
transfected with FLAG-RIG-I or FLAG-GFP. 24 h later, cells were infected with HSV-1WT 
(revertant) or HSV-1Δvhs (both MOI 10) for 16 h, or left uninfected (Mock). RNA bound to 
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FLAG-RIG-I or FLAG-GFP was precipitated from cell lysates using anti-FLAG PD as 
described in Figure 1a, followed by qRT-PCR analysis to assess bound RNA5SP141 
transcripts. (f) qRT-PCR analysis of IFNB1 mRNA in NHLF cells infected with HSV-1WT 
(revertant) or HSV-1Δvhs (both MOI 1) for 16 h and 24 h, or left uninfected (Mock). (g) qRT-
PCR analysis of IFNB1 transcripts in HEK 293T cells transfected with the indicated siRNAs 
for 30 h and then transfected with either no RNA (Mock) or 1 pmol of in vitro–transcribed 
RNA5SP141 for 16 h. (h) IFN-β luciferase reporter activity in HEK 293T cells transfected 
for 30 h with the indicated amounts of plasmids expressing FLAG-tagged RPL5, MRPL18, 
or TST and subsequently transfected with 1 pmol of RNA5SP141 for 16 h to stimulate RIG-
I signaling. Expression of FLAG-tagged proteins was confirmed in the WCL by IB with 
anti-FLAG. Data are representative of two (a, c-f), one (b) or three (g, h) independent 
experiments (mean and s.d. of n = 3 technical replicates in e, n = 2 biological replicates in c, 
f, and h, or n = 3 biological replicates in g). *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired 
t-test). NS, statistically not significant.
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Figure 5. 
RNA5SP141 mediates cytokine responses to HSV-1 and EBV. (a) qRT-PCR analysis of 
IFNB1 mRNA in NHLF cells transfected with either non-targeting control siRNA (si.Ctrl), 
or siRNAs targeting RIG-I (si.RIG-I) or RNA5SP141 (si.5SP141) for 72 h and then infected 
with HSV-1 (MOI 0.1) for 16 h, or left uninfected (Mock). Cells transfected with 1 pmol in 
vitro–transcribed RABVLe or 0.05 µg/mL HMW-poly(I:C) for 16 h served as controls. (b) 
Left, middle left: qRT-PCR analysis of IFNB1 and TNF mRNA in HEK 293T cells 
transfected with the indicated siRNAs as in (a) followed by infection with SeV (50 HAU/ml) 
for 16 h. Middle right, right: Knockdown efficiency of endogenous RIG-I (DDX58) and 
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RNA5SP141 was confirmed by qRT-PCR analysis. (c) qRT-PCR analysis of IFNB1, CCL5, 
and TNF mRNA in NHLF cells transfected with either non-targeting control gapmer (Gap 
NT), or two different gapmers targeting RIG-I (Gap RIG-I_1 and Gap RIG-I_2) or 
RNA5SP141 (Gap 5SP141_1 and Gap 5SP141_2) for 72 h and then infected with HSV-1 
(MOI 0.1) for 16 h. (d) qRT-PCR analysis of IFNB1 and IFIT1 mRNA in NHLF cells 
transfected as in (c) and then infected with SeV (25 HAU/mL) for 16 h. (e) qRT-PCR 
analysis of TNF mRNA in AGS-EBV cells transfected with the indicated siRNAs for 72 h, 
followed by treatment with 2.5 mM sodium butyrate (NaB) for 24 h to induce EBV 
reactivation. (f) Left, middle: qRT-PCR analysis of IL6 and IL8 mRNA in AGS-EBV cells 
transfected with the indicated siRNAs for 72 h, followed by treatment with 2.5 mM NaB for 
the indicated times to induce EBV reactivation. Right: EBV reactivation was confirmed by 
qRT-PCR analysis of EBV early gene BMRF1 mRNA. (g) ELISA of IL-8 in the 
supernatants of AGS-EBV cells that were transfected with the indicated siRNAs for 72 h, 
followed by treatment with 2.5 mM NaB for 24 h to induce EBV reactivation. (h) 
Abundance of endogenous TST, MRPL18, and RPL5 proteins in the WCLs of AGS-EBV 
cells treated with 2.5 mM NaB for the indicated times, determined by IB. IB analysis of 
EBV early antigen-restricted p85 (Ea-R p85) and cellular actin served as infection and 
loading controls, respectively. Data are representative of two (a, b, f, g, h) or three (c, d, e) 
independent experiments (mean and s.d. of n = 3 biological replicates in a, b, c, d, and f, n = 
2 biological replicates in e and g). *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired t-test). NS, 
statistically not significant.
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Figure 6. 
RNA5SP141 contributes to the induction of antiviral immunity to IAV. (a–c) qRT-PCR 
analysis of IFNB1, IFIT2, and CCL5 mRNA in NHLF cells transfected with either non-
targeting control siRNA (si.Ctrl), or siRNAs targeting RIG-I (si.RIG-I) or RNA5SP141 (si.
5SP141) for 72 h and then infected with IAV (MOI 0.01) for 16 h. Cells transfected with 1 
pmol RABVLe or 0.05 µg/mL HMW-poly(I:C) for 16 h served as controls. (d) ELISA 
analysis of IFN-β (left) and CCL5 (right) in the supernatants of NHLF cells that were 
transfected as in (a) and subsequently infected with IAV (MOI 0.1) for 24 h. (e) qRT-PCR 
analysis of IFNB1 mRNA in NHLF cells transfected with either non-targeting control 
gapmer (Gap NT), or gapmers targeting RIG-I (Gap RIG-I_1 and Gap RIG-I_2) or 
RNA5SP141 (Gap 5SP141_1 and Gap 5SP141_2) for 72 h and then infected with IAV (MOI 
0.05) for the indicated times. (f) qRT-PCR analysis of IFIT1 and ISG15 mRNA in NHLF 
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cells transfected with gapmers as in (e) and then infected with IAV (MOI 0.1) for 16 h. (g) 
Protein abundance of endogenous TST, MRPL18, and RPL5 in the WCLs of NHLF cells 
infected with IAV (MOI 5) for the indicated times, determined by IB. IB analysis of IAV 
non-structural protein 1 (NS1) and cellular Actin served as infection and loading controls, 
respectively. Data are representative of two independent experiments (mean and s.d. of n = 3 
biological replicates in a, b, c and f, n = 2 biological replicates in d and e). *P < 0.05, **P < 
0.01, ***P < 0.001 (unpaired t-test). ND, not detectable.
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